[Form 4] VIAVI SOLUTIONS INC. Insider Trading Activity

Rhea-AI Filing Summary

Viavi Solutions (VIAV) reported an insider equity change by a director. On November 7, 2025, restricted stock units vested and converted into 23,529 shares of common stock at $0 per share (transaction code M). Following the settlement, the director directly holds 142,497 shares.

The RSUs convert one-for-one into common stock and vested 100% on November 7, 2025; the reported RSU balance from this grant is now 0. The filing does not show any share sales.

Insights

Insider transactions analyst

Routine RSU vesting into 23,529 shares; no sales disclosed.

A director at Viavi Solutions reported the vesting and settlement of RSUs into 23,529 common shares at $0 on November 7, 2025 (code M). After this conversion, direct ownership is 142,497 shares.

This is a non-cash equity award settlement; no dispositions were listed. The RSUs vest 100% on November 7, 2025 and convert one-for-one, aligning with standard compensation mechanics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Black Laura A.

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

AZ 85286

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2025		M(1)		23,529	A	$0	142,497	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0	11/07/2025		M(1)			23,529	(2)	(3)	Common Stock	23,529	$0	0	D

Explanation of Responses:

1. Each stock unit converts upon vesting into one share of common stock.

2. Units vest 100% on November 7, 2025.

3. There are no expiration dates on RSUs.

	/s/ Donna T. Rossi, attorney-in-fact	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did VIAV disclose in this Form 4?

A director’s RSUs vested and converted into 23,529 common shares at $0 on November 7, 2025 (code M).

How many VIAV shares does the insider hold after the transaction?

The director directly holds 142,497 shares following the conversion.

Were any VIAV shares sold in this filing?

No. The filing reports RSU settlement only; no sales were disclosed.

What does transaction code M mean in this context?

Code M indicates a conversion of a derivative security, here RSUs converting into common stock.

What were the RSU vesting terms?

The RSUs vest 100% on November 7, 2025 and convert one-for-one into common stock.

What is the exercise price for the RSUs?

The RSUs converted at an exercise price of $0 per share.